SBI Securities’s Clearside Biomedical CLSD Stock Holding History

SBI Securities’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51	Closed	-$202	–	4065
2025 Q3	$202	Sell	51 -1	-2%	-$7	﹤0.01%	3315
2025 Q2	$626	Buy	52 +20	+63%	+$248	﹤0.01%	2872
2025 Q1	$445	Buy	32 +7	+28%	+$101	﹤0.01%	2911
2024 Q4	$361	Buy	+25	New	+$411	﹤0.01%	3015

Other funds holding CLSD

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

SBI Securities's CLSD Position: Q4 2025 in Review

SBI Securities sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 51 shares — an estimated $202 sold.

SBI Securities first reported a position in CLSD in Q4 2024 and held it in 4 quarters. The position peaked at $626 in Q2 2025. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.

SBI Securities reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 51 Clearside Biomedical shares in Q4 2025, an estimated $202.
SBI Securities first reported a position in Clearside Biomedical in Q4 2024 and held it in 4 quarters.
SBI Securities's Clearside Biomedical position peaked at $626 in Q2 2025.
1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.